We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
The Adverse Weather and Health Plan aims to protect individuals and communities from the health effects of adverse weather and to build community resilience.
Topical steroid products are safe and highly effective treatments for the management of a wide range of inflammatory skin diseases but have important risks, especially with prolonged use at high potency. In the coming months, as a result of regulatory...
Guidance about adverse possession of registered land. Aimed at conveyancers (practice guide 4).
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Device-specific guidance for manufacturers on reporting adverse incidents under the vigilance system
Explainer for the pharmaceutical industry on the implementation of the Veterinary Medicines Regulation relating to Pharmacovigilance.
Who you should contact if a pet or other animal or human has an unexpected reaction to a veterinary medicine or a problem with a microchip
Guidance on adverse possession where a right to be registered was acquired before 13 October 2003 (practice guide 5).
Explainer for the pharmaceutical industry on the implementation of Pharmacovigilance requirements during the transition time from the date the revised VMR have effect in GB to 17 May 2027.
Healthcare professionals should be vigilant for suspected adverse reactions and safety concerns associated with e-cigarettes and e-liquids, commonly known as vapes. Please report adverse reactions to the Yellow Card scheme and promote vigilance among patients.
How investigators and sponsors should manage clinical trials during COVID-19
Find out if a claim of ownership by adverse possession can be made on common land and town or village greens, what effect it will have on the land and whether a claim can be opposed.
Details of the Yellow Card scheme, which is the system for recording adverse incidents with medicines and medical devices in the UK.
For manufacturers reporting adverse incidents with IVC filters under the vigilance system.
This was a observational study, using data collected at all multidrug-resistant-TB treatment centres in Nigeria
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).